Medicamen Organics bulk deals and insider trading
NSE: MEDIORGPharmaceuticals & Biotechnology
Medicamen Organics Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2024 · Issue price ₹34
Last close ₹26.50up ₹1.25 (4.95%)
Share price at the NSE close on 30 Oct 2026. Previous close ₹25.25.
30 Oct: open ₹26.50, high ₹26.50, low ₹26.50
52-week range of traded prices to 30 Oct 2026
₹19.10Low, 12 Jun 2026₹35.15High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹39 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −13.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.50
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 54,000100.0% delivered
Medicamen Organics' insiders have 4 trade disclosures on record, the latest on 29 Sep 2026. Its promoter group made no purchase or sale on the market in the 12 months to 30 Oct 2026.
Promoter and insider buying and selling
Trades made since 31 Oct 2025.Medicamen Organics promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Medicamen Organics insider trading
Jul 2026
- BAL KISHAN GUPTA₹9.54 Cr38,62,650 sharesSold or invoked · Promoter And Designated Person · 24 Jul 2026 · disclosed 29 Sep
- BAL KISHAN GUPTA₹9.54 Cr38,62,650 sharesBought · Promoter And Designated Person · 24 Jul 2026 · disclosed 29 Sep
Mar 2026
- BAL KISHAN GUPTA₹8.50 Cr38,62,650 sharesSold or invoked · Promoter And Designated Person · 16 Mar 2026 · disclosed 7 Apr
- BAL KISHAN GUPTA₹8.50 Cr38,62,650 sharesBought · Promoter And Designated Person · 16 Mar 2026 · disclosed 7 Apr
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Medicamen Organics bulk deals
Last 12 months, since 31 Oct 2025: 4 bulk deals, ₹0.16 Cr bought and ₹0.53 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Monday 1 Jun 20261 firm · ₹0.16 Cr bought · ₹0 soldNet bought ₹0.16 Cr
- BoughtABHISHEK KAUSHIKBought 76,000 at ₹21.600.65% of the company₹0.16 Cr
Friday 10 Apr 20261 firm · ₹0 bought · ₹0.22 Cr soldNet sold ₹0.22 Cr
- SoldSB OPPORTUNITIES FUND ISold 78,000 at ₹28.270.64% of the company₹0.22 Cr
Thursday 9 Apr 20261 firm · ₹0 bought · ₹0.18 Cr soldNet sold ₹0.18 Cr
- SoldSB OPPORTUNITIES FUND ISold 60,000 at ₹29.230.49% of the company₹0.18 Cr
Tuesday 10 Mar 20261 firm · ₹0 bought · ₹0.14 Cr soldNet sold ₹0.14 Cr
- SoldSB OPPORTUNITIES FUND ISold 64,000 at ₹21.470.53% of the company₹0.14 Cr
Tuesday 6 Aug 20241 firm · ₹0 bought · ₹0.48 Cr soldNet sold ₹0.48 Cr
- SoldMANSI SHARE AND STOCK ADVISORS PVT LTDSold 72,000 at ₹66.990.62% of the company₹0.48 Cr
Monday 29 Jul 20241 firm · ₹0.49 Cr bought · ₹0.52 Cr soldNet sold ₹0.03 Cr
- Both waysSUMICKSHA BANSALBought 56,000 at ₹87.05Sold 60,000 at ₹85.940.51% of the companyNet −4,000 shares₹0.49 Cr bought
Friday 12 Jul 20242 firms · ₹1.67 Cr bought · ₹1.76 Cr soldNet sold ₹0.10 Cr
- SoldCINCO STOCK VISION LLPSold 1,40,000 at ₹118.951.20% of the company₹1.67 Cr
- Both waysMANSI SHARE AND STOCK ADVISORS PVT LTDBought 1,40,000 at ₹118.95Sold 8,000 at ₹121.001.20% of the companyNet +1,32,000 shares₹1.67 Cr bought
Friday 5 Jul 20241 firm · ₹0.85 Cr bought · ₹0.38 Cr soldNet bought ₹0.47 Cr
- Both waysMANSI SHARE AND STOCK ADVISORS PVT LTDBought 68,000 at ₹125.25Sold 28,000 at ₹135.290.58% of the companyNet +40,000 shares₹0.85 Cr bought
Thursday 4 Jul 20241 firm · ₹0.79 Cr bought · ₹0 soldNet bought ₹0.79 Cr
- BoughtMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 60,000 at ₹131.850.51% of the company₹0.79 Cr
Wednesday 3 Jul 20242 firms · ₹1.94 Cr bought · ₹1.27 Cr soldNet bought ₹0.67 Cr
- BoughtCINCO STOCK VISION LLPBought 1,40,000 at ₹138.551.20% of the company₹1.94 Cr
- SoldASHWIN STOCKS AND INVESTMENT PRIVATE LIMITEDSold 92,000 at ₹138.550.79% of the company₹1.27 Cr
Tuesday 2 Jul 20242 firms · ₹1.47 Cr bought · ₹3.22 Cr soldNet sold ₹1.75 Cr
- SoldMANSI SHARE AND STOCK ADVISORS PVT LTDSold 2,08,000 at ₹154.751.78% of the company₹3.22 Cr
- BoughtASHWIN STOCKS AND INVESTMENT PRIVATE LIMITEDBought 92,000 at ₹159.400.79% of the company₹1.47 Cr
Monday 1 Jul 20244 firms · ₹5.06 Cr bought · ₹3.63 Cr soldNet bought ₹1.43 Cr
- Both waysMANSI SHARE AND STOCK ADVISORS PVT LTDBought 2,60,000 at ₹137.50Sold 1,00,000 at ₹148.962.22% of the companyNet +1,60,000 shares₹3.58 Cr bought
- BoughtSAURABH TRIPATHIBought 1,00,000 at ₹142.980.85% of the company₹1.43 Cr
- SoldMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSold 80,000 at ₹137.500.68% of the company₹1.10 Cr
- Both waysSETU SECURITIES PVT LTDBought 4,000 at ₹150.00Sold 76,000 at ₹137.500.65% of the companyNet −72,000 shares₹0.06 Cr bought
Friday 28 Jun 20245 firms · ₹8.14 Cr bought · ₹0 soldNet bought ₹8.14 Cr
- BoughtSELVAMURTHY AKILANDESWARIBought 2,00,000 at ₹135.09₹2.70 Cr
- BoughtANKUSH KEDIABought 1,52,000 at ₹130.95₹1.99 Cr
- BoughtMANSI SHARE AND STOCK ADVISORS PVT LTDBought 1,00,000 at ₹136.19₹1.36 Cr
- BoughtMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 80,000 at ₹134.41₹1.08 Cr
- BoughtSETU SECURITIES PVT LTDBought 76,000 at ₹133.17₹1.01 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 27 deals on record since listing on 28 Jun 2024.